fig1
![The role of immune checkpoint inhibitors in triple-negative breast cancer: recent developments and future perspectives](https://image.oaes.cc/99de3048-57dc-4b97-a505-4ff46f9c9906/4390.fig.1.jpg)
Figure 1. CD80/86:CTLA-4 interactions and CTL-4 blockade with monoclonal antibodies.
Figure 1. CD80/86:CTLA-4 interactions and CTL-4 blockade with monoclonal antibodies.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/